September 15-18, 2025
Hynes Convention CenterBoston, MAKey Sessions
Sarah Glaven
The U.S. Biotechnology and Biomanufacturing Initiative
White House Office of Science and Technology Policy
Marinna Madrid
An AI- and Laser-based Biomanufacturing Platform to Scale Production of Personalized Regenerative Cell Therapies
Cellino
Ciaran Brady
Lessons Learned During the Commercialization of Casgevy™, the First CRISPR-Cas 9 Derived Therapy to be Commercially Approved
Vertex Pharmaceuticals Inc.